Despite challenging real estate market conditions, continued activities such as remarkable scientific progress and the use of artificial intelligence in drug discovery and clinical trials offer a bright spot. Breakthroughs in treating metabolic and neurodegenerative diseases, as well as advancements in cell therapies, require a careful reevaluation of infrastructure. JLL Life Sciences supports the evolving needs and provides valuable guidance and insights to industry leaders looking to fuel the next…
